| 1 |
国家卫生计生委,国家食品药品监管总局. 关于印发干细胞临床研究管理办法（试行）的通知[EB/OL].(2015-08-21)[2023-11-16].
URL
|
| 2 |
Zhou W, Lin J, Zhao K, et al. Single-cell profiles and clinically useful properties of human mesenchymal stem cells of adipose and bone marrow origin[J].Am J Sports Med, 2019, 47(7):1722-1733.
|
| 3 |
Silva JD, Lopes-Pacheco M, Paz AHR, et al. Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome[J].Crit Care Med, 2018, 46(2):e132-e140.
|
| 4 |
Hoang VT, Trinh QM, Phuong DTM, et al. Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources[J]. Cytotherapy, 2021, 23(1):88-99.
|
| 5 |
Han I, Kwon BS, Park HK, et al. Differentiation potential of mesenchymal stem cells is related to their intrinsic mechanical properties[J]. Int Neurourol J, 2017, 21(Suppl 1):S24-S31.
|
| 6 |
Song Y, Lim JY, Lim T, et al. Human mesenchymal stem cells derived from umbilical cord and bone marrow exert immunomodulatory effects in different mechanisms[J]. World J Stem Cells, 2020,12(9):1032-1049.
|
| 7 |
Itakura G, Kawabata S, Ando M, et al. Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives[J]. Stem Cell Reports, 2017, 8(3):673-684.
|
| 8 |
Deng J, Zhang Y, Xie Y, et al. Cell transplantation for spinal cord injury: tumorigenicity of induced pluripotent stem cell-derived neural stem/progenitor cells[J]. Stem Cells Int, 2018, 2018:5653787. doi: 10.1155/2018/5653787.
|
| 9 |
国家卫生健康委员会. 脐带血造血干细胞库设置管理有关回应[EB/OL].(2019-07-04) [2023-12-12].
URL
|
| 10 |
Shi M, Li YY, Xu RN, et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: a long-term follow-up analysis of the randomized controlled clinical trial[J]. Hepatol Int, 2021, 15(6):1431-1441.
|
| 11 |
张骏飞,宋海燕,陈曦, 等. 多次人脐带间充质干细胞移植治疗失代偿期乙型肝炎肝硬化患者临床研究[J].实用肝脏病杂志, 2018, 21(5):693-696.
|
| 12 |
Jia Y, Shu X, Yang X, et al. Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis[J]. Stem Cell Res Ther, 2020, 11(1):277. doi: 10.1186/s13287-020-01787-4.
|
| 13 |
陶立元, 李楠, 赵一鸣. 临床研究的样本量估算及其影响因素[J].中华儿科杂志, 2015, 53(9):643.
|
| 14 |
谢丽, 路茂杰, 沈力, 等. 我国干细胞临床试验方案设计常见问题及其优化措施[J].中国医药生物技术, 2019, 14(3):280-285, 272.
|
| 15 |
Wu J, Menon S, Chang M. An adaptive staggered dose design for a normal endpoint[J]. J Biopharm Stat, 2015, 25(4):731-756.
|
| 16 |
Ishizuka B. Current understanding of the etiology, symptomatology, and treatment options in premature ovarian insufficiency (POI)[J]. Front Endocrinol (Lausanne), 2021, 12:626924. doi: 10.3389/fendo.2021.626924.
|
| 17 |
Ding L, Yan G, Wang B, et al. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility[J]. Sci China Life Sci, 2018, 61(12):1554-1565.
|
| 18 |
Yan L, Wu Y, Li L, et al. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency[J]. Cell Prolif, 2020, 53(12):e12938. doi: 10.1111/cpr.12938.
|
| 19 |
Cudkowicz ME, Lindborg SR, Goyal NA, et al. A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis[J]. Muscle Nerve, 2022, 65(3):291-302.
|
| 20 |
Wernicke CM, Grunewald TG, Hendrik J, et al. Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases[J]. Int Arch Med, 2011, 4(1):27.doi: 10.1186/1755-7682-4-27.
|
| 21 |
国家市场监督管理总局.《药品注册管理办法》[EB/OL]. (2020-01-22)[2023-11-16].
URL
|
| 22 |
国家食品药品监管总局.总局关于发布细胞治疗产品研究与评价技术指导原则的通告[EB/OL]. (2017-12-18)[2023-11-16].
URL
|
| 23 |
国家药监局药审评中心.关于发布《人源性干细胞及其衍生细胞治疗产品临床试验技术指导原则（试行）》的通告[EB/OL].(2023-06-21)[2023-11-16].
URL
|